Skip to main content

Advertisement

SpringerLink
Log in

Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess

  • Case Report
  • Published:
Clinical and Experimental Nephrology Aims and scope Submit manuscript

Abstract

A 68-year-old female in hemodialysis due to autosomal dominant polycystic kidney disease underwent resection of cysts in her right kidney via a laparoscopic approach due to abdominal pain. Three weeks after surgery, she was admitted with sepsis. A CT scan showed a large abscess around the right kidney. Percutaneous drainage of abscess was performed. The pus smear showed Gram-positive cocci and the culture contained methicillin-resistant Staphylococcus aureus. Ciprofloxacin, clindamycin and vancomycin were given. In the 3 weeks following admission, she remained febrile and septic and showed a progressive deterioration in her general condition, along with malnutrition and persistent drainage of purulent material from her right flank. The antibiotic therapy was changed to vancomycin, metronidazole and meropenem, but no improvement was observed. Because of the high risk associated with carrying out an open nephrectomy, we decided to use hyperbaric oxygen therapy (HBOT) as a potentially useful measure to control her infection. The patient underwent 26 daily sessions of 100% hyperbaric oxygen (2.5 atm). The use of HBOT induced a notable break in the clinical course of this patient’s retroperitoneal infection. She was discharged after day 58 without any signs of inflammatory activity, and she has not presented reactivation of infection since then. We think that this case suggests that this therapy could be a new therapeutic tool in the management of patients with similar clinical features when all other therapeutic measures have failed. We did not find any other reports of the use of HBOT in infections of renal cysts.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Sallée M, Rafat C, Zahar JR, Paulmier B, Grünfeld JP, Knebelmann B, et al. Cyst infections in patients with autosomal dominant polycystic kidney disease. Clin J Am Soc Nephrol. 2009;4(7):1183–9.

    Article  PubMed  Google Scholar 

  2. Hemal AK, Gupta NP, Rajeev TP, Aron M, Bhowmik D, Jain R. Retroperitoneoscopic management of infected cysts in adult polycystic kidney disease. Urol Int. 1999;62(1):40–3.

    Article  CAS  PubMed  Google Scholar 

  3. Christophe JL, van Ypersele de Strihou C, Pirson Y. Complications of autosomal dominant polycystic kidney disease in 50 haemodialysed patients. A case–control study. The UCL Collaborative Group. Nephrol Dial Transplant. 1996;11(7):1271–6.

    Google Scholar 

  4. Ohshima S, Fujita T, Ono Y, Katoh N, Matsuura O, Takeuchi N, et al. End stage polycystic kidney disease: the study for upper urinary tract infection & hemorrhage into the cysts. Nippon Hinyokika Gakkai Zasshi. 1994;85(11):1673–8.

    CAS  PubMed  Google Scholar 

  5. Palou J, Monreal F, Caparrós J, Marti J, Calero F, Ballarín J. Percutaneous drainage by multiple and bilateral puncture of infected renal cysts in autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 1998;13(6):1606–8.

    Article  CAS  PubMed  Google Scholar 

  6. Dembry LM, Andriole VT. Renal and perirenal abscesses. Infect Dis Clin N Am. 1997;11(3):663–80.

    Article  CAS  Google Scholar 

  7. Desai PJ, Castle EP, Daley SM, Swanson SK, Ferrigni FG, Humphreys MR, et al. Bilateral laparoscopic nephrectomy for significantly enlarged polycystic kidneys: a technique to optimize outcome in the largest of specimens. BJU Int. 2008;101(8):1019–23.

    Article  PubMed  Google Scholar 

  8. Takaiwa M, Nakano M, Koseki K, Yoshida J, Iwasaki M, Kuma Y, et al. A case of embolization to a large polycystic kidney with infection. Nippon Hinyokika Gakkai Zasshi. 2000;91(7–8):595–8.

    CAS  PubMed  Google Scholar 

  9. Lipke MC, Bargman V, Milgrom M, Sundaram CP. Limitations of laparoscopy for bilateral nephrectomy for autosomal dominant polycystic kidney disease. J Urol. 2007;177(2):627–31.

    Article  PubMed  Google Scholar 

  10. Parsons JK, Varkarakis I, Rha KH, Jarrett TW, Pinto PA, Kavoussi LR. Complications of abdominal urologic laparoscopy: longitudinal five-year analysis. Urology. 2004;63(1):27–32.

    Article  PubMed  Google Scholar 

  11. Hemal AK. Laparoscopic management of renal cystic disease. Urol Clin N Am. 2001;28(1):115–26.

    Article  CAS  Google Scholar 

  12. Dunn MD, Portis AJ, Naughton C, Shalhav A, McDougall EM, Clayman RV. Laparoscopic cyst marsupialization in patients with autosomal dominant polycystic kidney disease. J Urol. 2001;165(6 Pt 1):1888–92.

    CAS  PubMed  Google Scholar 

  13. Lifson BJ, Teichman JM, Hulbert JC. Role and long-term results of laparoscopic decortication in solitary cystic and autosomal dominant polycystic kidney disease. J Urol. 1998;159(3):702–5.

    Article  CAS  PubMed  Google Scholar 

  14. Lee DI, Andreoni CR, Rehman J, Landman J, Ragab M, Yan Y, et al. Laparoscopic cyst decortication in autosomal dominant polycystic kidney disease: impact on pain, hypertension, and renal function. J Endourol. 2003;17(6):345–54.

    Article  PubMed  Google Scholar 

  15. McNally ML, Erturk E, Oleyourryk G, Schoeniger L. Laparoscopic cyst decortication using the harmonic scalpel for symptomatic autosomal dominant polycystic kidney disease. J Endourol. 2001;15(6):597–9.

    Article  CAS  PubMed  Google Scholar 

  16. Elashry OM, Nakada SY, Wolf JS Jr, McDougall EM, Clayman RV. Laparoscopy for adult polycystic kidney disease: a promising alternative. Am J Kidney Dis. 1996;27(2):224–33.

    Article  CAS  PubMed  Google Scholar 

  17. Fryczkowski M, Huk J, Sitko-Saucha A, Kupilas A. Place of laparoscopic cysts decortication (LCD) in the treatment of autosomal dominant polycystic kidney disease (AD PKD). Prog Urol. 2007;17(7):1324–7.

    Article  PubMed  Google Scholar 

  18. Leach RM, Rees PJ, Wilmshurst P. Hyperbaric oxygen therapy. BMJ. 1998;317(7166):1140–3.

    CAS  PubMed  Google Scholar 

  19. Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med. 1996;334(25):1642–8.

    Article  CAS  PubMed  Google Scholar 

  20. Clark LA, Moon RE. Hyperbaric oxygen in the treatment of life-threatening soft-tissue infections. Respir Care Clin N Am. 1999;5(2):203–19.

    CAS  PubMed  Google Scholar 

  21. Gibson P, Watson ML. Cyst infection in polycystic kidney disease: a clinical challenge. Nephrol Dial Transplant. 1998;13(10):2455–7.

    Article  CAS  PubMed  Google Scholar 

  22. Alam A, Perrone RD. Managing cyst infections in ADPKD: an old problem looking for new answers. Clin J Am Soc Nephrol. 2009;4(7):1154–5.

    Article  PubMed  Google Scholar 

  23. Gama KS, Pérez CN, Simó VE, Serna MR. Emphysematous pyelonephritis and radical nephrectomy in hepatorenal polycystosis. Nefrologia. 2010;30(1):140–1.

    PubMed  Google Scholar 

  24. Van Zijl PS, Chai TC. Gas-forming infection from Clostridium perfringens in a renal cyst of a patient with autosomal dominant polycystic kidney disease. Urology. 2004;63(6):1178–9.

    Article  PubMed  Google Scholar 

  25. Hiyama L, Tang A, Miller LG. Levofloxacin penetration into a renal cyst in a patient with autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2006;47(1):e9–13.

    Article  PubMed  Google Scholar 

  26. Ercoc R, Sayarlioglu H, Ceylan K, Dogan E, Kara PS. Gas-forming infection in a renal cyst of a patient with autosomal dominant polycystic kidney disease. Nephrol Dial Transplant. 2006;21(2):555–6.

    Article  Google Scholar 

  27. Nadu A, Hoznek A, Salomon L, Saint F, Cicco A, Olsson LE, et al. Laparoscopic retroperitoneal nephrectomy for Aspergillus-infected polycystic kidney. J Endourol. 2002;16(4):237–40.

    Article  PubMed  Google Scholar 

  28. Jungers P, Albouze G, Aime F. Problemes poses par l’hemodialyse periodique et la transplantation rénale chez les maladies atteints de maladie polykystique renale. In: Küss R, Legrain M, editors. Seminaries d’Uro-Nephrologie. Paris: Masson; 1983. p. 12–37.

    Google Scholar 

  29. Moon RE, Sheffield PJ. Guidelines for treatment of decompression illness. Aviat Space Environ Med. 1997;68(3):234–43.

    CAS  PubMed  Google Scholar 

  30. Kol S, Ammar R, Weisz G, Melamed Y. Hyperbaric oxygenation for arterial air embolism during cardiopulmonary bypass. Ann Thorac Surg. 1993;55(2):401–3.

    Article  CAS  PubMed  Google Scholar 

  31. Norkool DM, Kirkpatrick JN. Treatment of acute monoxide poisoning with hyperbaric oxygen: a review of 115 cases. Ann Emerg Med. 1985;14(12):1168–71.

    Article  CAS  PubMed  Google Scholar 

  32. Aydinoz S, Uzun G, Cermik H, Atasoyu EM, Yildiz S, Karagoz B, et al. Effects of different doses of hyperbaric oxygen on cisplatin-induced nephrotoxicity. Ren Fail. 2007;29(3):257–63.

    Article  CAS  PubMed  Google Scholar 

  33. Ay H, Uzun G, Onem Y, Aydinoz S, Yildiz S, Bilgi O, et al. Effect of hyperbaric oxygen on cyclosporine-induced nephrotoxicity and oxidative stress in rats. Ren Fail. 2007;29(4):495–501.

    Article  CAS  PubMed  Google Scholar 

  34. Rubinstein I, Abassi Z, Milman F, Ovcharenko E, Coleman R, Winaver J, et al. Hyperbaric oxygen treatment improves GFR in rats with ischaemia/reperfusion renal injury: a possible role for the antioxidant/oxidant balance in the ischaemic kidney. Nephrol Dial Transplant. 2009;24(2):428–36.

    Article  CAS  PubMed  Google Scholar 

  35. Sonmez A, Yilmaz MI, Korkmaz A, Topal T, Caglar K, Kaya A, et al. Hyperbaric oxygen treatment augments the efficacy of cilazapril and simvastatin regimens in an experimental nephrotic syndrome model. Clin Exp Nephrol. 2008;12(2):110–8.

    Article  CAS  PubMed  Google Scholar 

  36. Arenas MD, Gil MT, Gutiérrez MD, Malek T, Moledous A, Salinas A, et al. Management of calcific uremic arteriolopathy (calciphylaxis) with a combination of treatments, including hyperbaric oxygen therapy. Clin Nephrol. 2008;70(3):261–4.

    CAS  PubMed  Google Scholar 

  37. Okhuysen PC, Rex JH, Kapusta M, Fife C. Successful treatment of extensive posttraumatic soft-tissue and renal infections due to Apophysomyces elegans. Clin Infect Dis. 1994;19(2):329–31.

    CAS  PubMed  Google Scholar 

  38. Chen CY, Lin KP, Lu SH, Chen YJ, Lin CF. Adjuvant hyperbaric oxygen therapy in the treatment of hemodialysis patients with chronic osteomyelitis. Ren Fail. 2008;30(2):233–7.

    Article  PubMed  Google Scholar 

  39. Miano M, Faraci M, Dini G, Bordigoni P, EBMT Paediatric Working Party. Early complications following haematopoietic SCT in children. Bone Marrow Transplant. 2008;41(Suppl 2):S39–42.

    Article  PubMed  Google Scholar 

  40. Latham E, Hare MA, Neumeister M. Hyperbaric oxygen therapy. http://emedicine.medscape.com/article/1464149-overview. Accessed 18 June 2010.

  41. Fick GM, Johnson AM, Hammond WS, Gabow PA. Causes of death in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 1995;5(12):2048–56.

    CAS  PubMed  Google Scholar 

  42. Rahman E, Niaz FA, Al-Suwaida A, Nahrir S, Bashir M, Rahman H, et al. Analysis of causes of mortality in patients with autosomal dominant polycystic kidney disease: a single center study. Saudi J Kidney Dis Transpl. 2009;20(5):806–10.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departamento de Medicina, Escuela de Medicina, Universidad de Valparaíso, 5 Norte 1035, Quinta Región, Viña del Mar, Chile

    Jorge Vega & Helmuth Goecke

  2. Servicio de Medicina Interna, Sección de Nefrología, Diálisis y Trasplante Renal, Hospital Naval Almirante Nef, Viña del Mar, Chile

    Jorge Vega, Helmuth Goecke & Francisco Manriquez

  3. Servicio de Medicina Interna, Sección de Nefrología, Diálisis y Trasplante Renal, Hospital Dr. Gustavo Fricke, Viña del Mar, Chile

    Jorge Vega & Christian Videla

  4. Servicio de Urología, Hospital Naval Almirante Nef, Viña del Mar, Chile

    Carlos Escobar & Max Escobar

  5. Servicio de Radiología, Hospital Naval Almirante Nef, Viña del Mar, Chile

    Mario Santamarina

  6. Servicio de Medicina Hiperbárica, Hospital Naval Almirante Nef, Viña del Mar, Chile

    Carlos Echeverria

  7. Escuela de Medicina, Pontificia Universidad Católica de Chile, Santiago, Chile

    Francisco Javier Guarda

Authors
  1. Jorge Vega
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Helmuth Goecke
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Francisco Manriquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Carlos Escobar
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Max Escobar
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Christian Videla
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Mario Santamarina
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Carlos Echeverria
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Francisco Javier Guarda
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jorge Vega.

About this article

Cite this article

Vega, J., Goecke, H., Manriquez, F. et al. Hyperbaric oxygen therapy in a patient with autosomal dominant polycystic kidney disease with a perinephritic abscess. Clin Exp Nephrol 15, 141–146 (2011). https://doi.org/10.1007/s10157-010-0348-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10157-010-0348-2

Keywords

Search

Navigation